ReviveMed discovers detailed molecular pathways associated with a disease.
We can reveal novel therapeutic targets by leveraging data from metabolites.
Using metabolomics, we identify new therapeutic effects for existing drugs or drugs in development.
Our solutions can reveal underlying molecular mechnisms through which a drug produces its pharmacological effect.
We discover mechanistic-based biomarker signature associated with a disease or a drug treatment from biofluid metabolomic data.
Using our proprietary database and machine-learning algorithm, we reduce the need for costly and time-consuming experiments to identify a large set of metabolites, and integrate these data with other large-scale molecular datasets such as genomics and proteomics.